Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C15H9FN2.ClH |
| Molecular Weight | 272.705 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
Cl.CC1=NC(=CC=C1)C#CC2=CC(F)=CC(=C2)C#N
InChI
InChIKey=WRHOKQFFLQKKNL-UHFFFAOYSA-N
InChI=1S/C15H9FN2.ClH/c1-11-3-2-4-15(18-11)6-5-12-7-13(10-17)9-14(16)8-12;/h2-4,7-9H,1H3;1H
| Molecular Formula | ClH |
| Molecular Weight | 36.461 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
| Molecular Formula | C15H9FN2 |
| Molecular Weight | 236.2438 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
DescriptionSources: https://www.ncbi.nlm.nih.gov/pubmed/21546249
Sources: https://www.ncbi.nlm.nih.gov/pubmed/21546249
MFZ 10-7 is a high affinity negative allosteric modulator at the mGlu5 receptor (Ki = 0.67 nM). MFZ 10-7 demonstrates anxyolitic properties in mouse models. Intraperitoneal administration of MFZ 10-7 inhibited intravenous cocaine self-administration, cocaine-induced reinstatement of drug-seeking behavior and cocaine-associated cue-induced cocaine-seeking behavior in rats.
CNS Activity
Originator
Approval Year
Targets
| Primary Target | Pharmacology | Condition | Potency |
|---|---|---|---|
Target ID: P41594 Gene ID: 2915.0 Gene Symbol: GRM5 Target Organism: Homo sapiens (Human) Sources: https://www.ncbi.nlm.nih.gov/pubmed/21546249 |
1.22 nM [IC50] |
Conditions
| Condition | Modality | Targets | Highest Phase | Product |
|---|---|---|---|---|
| Primary | Unknown Approved UseUnknown |
|||
| Primary | Unknown Approved UseUnknown |
PubMed
| Title | Date | PubMed |
|---|---|---|
| A novel mGluR5 antagonist, MFZ 10-7, inhibits cocaine-taking and cocaine-seeking behavior in rats. | 2014-03 |
|
| Metabotropic glutamate receptor 5 negative allosteric modulators as novel tools for in vivo investigation. | 2012-07-12 |
|
| Potent mGluR5 antagonists: pyridyl and thiazolyl-ethynyl-3,5-disubstituted-phenyl series. | 2011-06-01 |
Patents
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/22924094
For anxyolitic tests MFZ 10-7 was delivered via ip injection 15 min prior to testing. Anxyolitic effects were observed at dose 0.3 mg/kg.
Route of Administration:
Intraperitoneal
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/21546249
MFZ 10-7 was evaluated for antagonism of glutamate-mediated mobilization of internal calcium in an mGluR5 in vitro assay. MFZ 10-7 (compound 2d) inhibited mGluR5 with IC50 1.22 nM.
| Substance Class |
Chemical
Created
by
admin
on
Edited
Wed Apr 02 16:01:44 GMT 2025
by
admin
on
Wed Apr 02 16:01:44 GMT 2025
|
| Record UNII |
T3EFD8HR3L
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Common Name | English | ||
|
Preferred Name | English | ||
|
Systematic Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
90488944
Created by
admin on Wed Apr 02 16:01:44 GMT 2025 , Edited by admin on Wed Apr 02 16:01:44 GMT 2025
|
PRIMARY | |||
|
1779796-36-9
Created by
admin on Wed Apr 02 16:01:44 GMT 2025 , Edited by admin on Wed Apr 02 16:01:44 GMT 2025
|
PRIMARY | |||
|
T3EFD8HR3L
Created by
admin on Wed Apr 02 16:01:44 GMT 2025 , Edited by admin on Wed Apr 02 16:01:44 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
PARENT -> SALT/SOLVATE |
|